Karen L. Furie

ORCID: 0000-0003-0065-3784
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Atrial Fibrillation Management and Outcomes
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Intracranial Aneurysms: Treatment and Complications
  • Venous Thromboembolism Diagnosis and Management
  • Stroke Rehabilitation and Recovery
  • Cardiac Imaging and Diagnostics
  • Neurosurgical Procedures and Complications
  • Neurological Disorders and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Health and Disease Prevention
  • S100 Proteins and Annexins
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cerebral Venous Sinus Thrombosis
  • Cardiovascular and Diving-Related Complications
  • Intensive Care Unit Cognitive Disorders
  • Folate and B Vitamins Research
  • Cardiovascular Function and Risk Factors
  • Blood Pressure and Hypertension Studies
  • Diabetes Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Neurological Disease Mechanisms and Treatments
  • Cerebrospinal fluid and hydrocephalus

Brown University
2016-2025

Rhode Island Hospital
2016-2025

Providence College
2016-2025

Karen Hospital
2013-2024

Cornell University
2010-2024

University of Thessaly
2024

University of Iowa
2015-2024

University of Pittsburgh
2015-2024

University of Washington
2003-2024

Instituto Nacional de Neurología y Neurocirugía
2024

The aim of this updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention future stroke among survivors ischemic or transient attack. addressed all clinicians who manage secondary for these patients. Evidence-based are provided control risk factors, intervention vascular obstruction, antithrombotic therapy cardioembolism, antiplatelet noncardioembolic stroke. Recommendations also recurrent in a variety specific circumstances, including aortic...

10.1161/str.0000000000000024 article EN Stroke 2014-05-02

Each year the American Heart Association, in conjunction with Centers for Disease Control and Prevention, National Institutes of Health, other government agencies, brings together most up-to-date statistics on heart disease, stroke, their risk factors presents them its Stroke Statistical Update.The Update is a valuable resource researchers, clinicians, healthcare policy makers, media, lay public, many others who seek best national data available disease factor prevalence, incidence,...

10.1161/circulationaha.107.187998 article EN Circulation 2007-12-18

The aim of this new statement is to provide comprehensive and timely evidence-based recommendations on the prevention ischemic stroke among survivors or transient attack. Evidence-based are included for control risk factors, interventional approaches atherosclerotic disease, antithrombotic treatments cardioembolism, use antiplatelet agents noncardioembolic stroke. Further provided recurrent in a variety other specific circumstances, including arterial dissections; patent foramen ovale;...

10.1161/01.str.0000199147.30016.74 article EN Stroke 2006-01-23

The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention ischemic stroke among survivors or transient attack. Evidence-based are included for control risk factors, interventional approaches atherosclerotic disease, antithrombotic treatments cardioembolism, use antiplatelet agents noncardioembolic stroke. Further provided recurrent in a variety other specific circumstances, including arterial dissections; patent foramen ovale;...

10.1161/str.0b013e3181f7d043 article EN Stroke 2010-10-22

Despite the use of antiplatelet agents, usually aspirin, in patients who have had an ischemic stroke, there is still a substantial rate recurrence. Therefore, we investigated whether warfarin, which effective and superior to aspirin prevention cardiogenic embolism, would also prove recurrent stroke with prior noncardioembolic stroke.

10.1056/nejmoa011258 article EN New England Journal of Medicine 2001-11-15

Patients with ischemic stroke or transient attack (TIA) are at increased risk for future cardiovascular events despite current preventive therapies. The identification of insulin resistance as a factor and myocardial infarction raised the possibility that pioglitazone, which improves sensitivity, might benefit patients cerebrovascular disease.

10.1056/nejmoa1506930 article EN New England Journal of Medicine 2016-02-17

Abstract Regular, evidence‐based assignment of patients to etiologic stroke categories is essential enable valid comparison among studies. We designed an algorithm (SSS‐TOAST) that incorporated recent advances in imaging and epidemiology identify the most probable TOAST category presence evidence for multiple mechanisms. Based on weight evidence, each subtype was subdivided into 3 subcategories as “evident”, “probable”, or “possible”. Classification determined via predefined specific...

10.1002/ana.20617 article EN Annals of Neurology 2005-10-20

The aim of this new statement is to provide comprehensive and timely evidence-based recommendations on the prevention ischemic stroke among survivors or transient attack. Evidence-based are included for control risk factors, interventional approaches atherosclerotic disease, antithrombotic treatments cardioembolism, use antiplatelet agents noncardioembolic stroke. Further provided recurrent in a variety other specific circumstances, including arterial dissections; patent foramen ovale;...

10.1161/circ.113.10.e409 article EN Circulation 2006-03-14

Pneumonia is an important complication of ischemic stroke and increases mortality 3-fold. Five guidelines recommend a dysphagia screen before oral intake. What constitutes adequate which patients should receive it remain unclear.Fifteen acute care institutions prospectively collected data on all admitted with stroke. Sites were required to collect demographics 4 quality indicators. Optional included severity complications. We measured adherence for dysphagia, the type screen, development...

10.1161/01.str.0000177529.86868.8d article EN Stroke 2005-08-19

Recurrent lobar intracerebral hemorrhage is the hallmark of cerebral amyloid angiopathy. The factors that predispose patients to early recurrence are unknown. One candidate apolipoprotein E gene, since both epsilon2 and epsilon4 alleles appear be associated with severity angiopathy.We performed a prospective, longitudinal study consecutive elderly who survived hemorrhage. were followed for recurrent hemorrhagic stroke by interviews at six-month intervals reviews medical records computed...

10.1056/nejm200001273420403 article EN New England Journal of Medicine 2000-01-27

Background and Purpose— Acute ischemic stroke due to large vessel occlusion (LVO)—vertebral, basilar, carotid terminus, middle anterior cerebral arteries—likely portends a worse prognosis than unassociated with LVO. Because little prospective angiographic data have been reported on cohort of unselected patients transient attack, the clinical impact LVO has difficult quantify. Methods— The Screening Technology Outcome Project in Stroke Study is imaging-based study outcomes performed at 2...

10.1161/strokeaha.109.561787 article EN Stroke 2009-10-16

The SSS-TOAST is an evidence-based classification algorithm for acute ischemic stroke designed to determine the most likely etiology in presence of multiple competing mechanisms. In this article, we present automated version SSS-TOAST, Causative Classification System (CCS), facilitate its utility multicenter settings.The CCS a web-based system that consists questionnaire-style scheme (http://ccs.martinos.org). Data entry provided via checkboxes indicating results clinical and diagnostic...

10.1161/strokeaha.107.490896 article EN Stroke 2007-09-28

10.1038/ng.1081 article EN Nature Genetics 2012-02-05
Coming Soon ...